Academic Jobs Logo

Rate My Professor Celia Gregson

University of Bristol

Manage Profile
5.00/5 · 1 review
5 Star1
4 Star0
3 Star0
2 Star0
1 Star0
5.05/4/2026

Fosters collaboration and teamwork.

About Celia

Professor Celia Gregson is a Professor of Clinical Epidemiology in the Musculoskeletal Research Unit, Bristol Medical School, University of Bristol. She qualified in medicine with a BMedSci and BMBS from the University of Nottingham, holds membership of the Royal College of Physicians (MRCP UK), an MSc, a PhD from the University of Bristol (2008-2011) in the School of Social and Community Medicine, a Certificate of Completion of Training (CCT), and fellowship of the Royal College of Physicians (FRCP). Her career includes an Arthritis Research UK Clinician Scientist Fellowship at the University of Bristol, where she served as Consultant Senior Lecturer and Honorary Consultant Geriatrician, before her appointment as Professor. She also holds the NIHR Global Health Research Professorship in Healthy Ageing in sub-Saharan Africa. Gregson leads the University of Bristol Global Musculoskeletal Health Research Programme and the Global Health and Ageing Research Unit (GHARU). She coordinates the High Bone Mass Study since 2007, recruiting over 555 participants across 15 UK centres, and serves as principal investigator for the Menopause Study funded by University of Bristol QR GCRF (£197,182). She founded the Sub-Saharan African Hip Fracture Registry and leads research on fragility fractures, HIV effects on bone health, and interventions like the IMVASK and VITALITY studies.

Her research specializations encompass the epidemiology and genetics of osteoporosis, high bone mineral density, hip fractures, and musculoskeletal health in low-resource settings, particularly sub-Saharan Africa. Key publications include co-authorship of the UK clinical guideline for the prevention and treatment of osteoporosis (Archives of Osteoporosis, 2017; 2022), 'An atlas of genetic influences on osteoporosis in humans and mice' (Nature Genetics, 2019), 'Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture' (Nature, 2015), and 'Osteosarcopenia: where osteoporosis and sarcopenia collide' (Rheumatology, 2021). She contributed to the REDUCE Study on hip fracture care, influencing national guidance, and received the NIHR Global Health Research Professorship award in 2023. Her work has garnered over 5,500 citations on Google Scholar, demonstrating significant impact on bone health research and global ageing.